Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Alp, Keziban Merve (1) Kobelt, Dennis Dr. (5) Popp, Oliver Dr. (2) Rehm, Armin Dr. (1) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (12) Walther, Wolfgang Prof. Dr. (8) Wolf, Jana Prof. Dr. (1) (-) Dahlmann, Mathias Dr. (4) (-) Mertins, Philipp Dr. (3) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (2) Animal Phenotyping (1) Biobank (1) Clinical Research Unit (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Hypertonie-vermittelter Endorganschaden (2) Hypertonie bedingte Endorganschäden (2) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (2) Molekulare Epidemiologie (1) Molekulare Herz- Kreislaufforschung (1) Myologie (1) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (1) Proteom Dynamik (1) Proteomics (12) Translational Bioinformatics (1) (-) Translationale Onkologie solider Tumore (5) Translationale Tumorimmunologie (1) 2010 (1) 2012 (1) 2014 (1) 2015 (2) 2016 (3) 2017 (2) 2018 (2) 2019 (2) 2020 (4) (-) 2021 (5) 2022 (10) 2023 (1) 5 Ergebnisse: Active Filter: Dahlmann, Mathias Dr.Mertins, Philipp Dr.Translationale Onkologie solider Tumore2021 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2021 / Methods Mol Biol A bioinformatic pipeline to identify biomarkers for metastasis formation from RNA sequencing data M. Dahlmann U.S. Stein 01. Januar 2021 / Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine M. Rivera I. Fichtner A. Wulf-Goldenberg C. Sers J. Merk G. Patone K.M. Alp T. Kanashova P. Mertins J. Hoffmann U. Stein W. Walther 26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein 01. April 2021 / Cell Mol Life Sci MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer F. Imbastari M. Dahlmann A. Sporbert C. Ciolli Mattioli T. Mari F. Scholz L. Timm S. Twamley R. Migotti W. Walther G. Dittmar A. Rehm U. Stein 21. Oktober 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein
01. Januar 2021 / Methods Mol Biol A bioinformatic pipeline to identify biomarkers for metastasis formation from RNA sequencing data M. Dahlmann U.S. Stein
01. Januar 2021 / Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine M. Rivera I. Fichtner A. Wulf-Goldenberg C. Sers J. Merk G. Patone K.M. Alp T. Kanashova P. Mertins J. Hoffmann U. Stein W. Walther
26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
01. April 2021 / Cell Mol Life Sci MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer F. Imbastari M. Dahlmann A. Sporbert C. Ciolli Mattioli T. Mari F. Scholz L. Timm S. Twamley R. Migotti W. Walther G. Dittmar A. Rehm U. Stein
21. Oktober 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein